Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY)
Author(s) -
Eric Jüttler,
Stefan Schwab,
Peter Schmiedek,
Andreas Unterberg,
Michael G. Hennerici,
Johannes Woitzik,
Steffen Witte,
Ekkehart Jenetzky,
Werner Hacke
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.485649
Subject(s) - medicine , modified rankin scale , randomized controlled trial , clinical endpoint , surgery , stroke (engine) , neurointensive care , middle cerebral artery , sample size determination , end point , anesthesia , ischemic stroke , ischemia , mechanical engineering , engineering , statistics , mathematics , geometry
Decompressive surgery (hemicraniectomy) for life-threatening massive cerebral infarction represents a controversial issue in neurocritical care medicine. We report here the 30-day mortality and 6- and 12-month functional outcomes from the DESTINY trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom